Compare MLAB & ETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLAB | ETO |
|---|---|---|
| Founded | 1982 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 447.4M | 471.2M |
| IPO Year | N/A | N/A |
| Metric | MLAB | ETO |
|---|---|---|
| Price | $80.40 | $29.67 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $83.00 | N/A |
| AVG Volume (30 Days) | ★ 104.9K | 26.5K |
| Earning Date | 02-03-2026 | 01-01-0001 |
| Dividend Yield | 0.79% | ★ 6.67% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $245,255,000.00 | N/A |
| Revenue This Year | $4.96 | N/A |
| Revenue Next Year | $5.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.39 | N/A |
| 52 Week Low | $55.45 | $19.85 |
| 52 Week High | $155.12 | $25.21 |
| Indicator | MLAB | ETO |
|---|---|---|
| Relative Strength Index (RSI) | 59.16 | 66.93 |
| Support Level | $76.52 | $28.20 |
| Resistance Level | $82.78 | $29.17 |
| Average True Range (ATR) | 2.57 | 0.34 |
| MACD | 0.11 | 0.04 |
| Stochastic Oscillator | 73.53 | 94.19 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.